Toward a Refined PI-RADS: The Feasibility and Limitations of More Informative Metrics in Reviewing MRI Scans.

IF 3.3 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Omer Tarik Esengur, Hunter Stecko, Emma Stevenson, Baris Turkbey
{"title":"Toward a Refined PI-RADS: The Feasibility and Limitations of More Informative Metrics in Reviewing MRI Scans.","authors":"Omer Tarik Esengur, Hunter Stecko, Emma Stevenson, Baris Turkbey","doi":"10.1002/jmri.29754","DOIUrl":null,"url":null,"abstract":"<p><p>The Prostate Imaging-Reporting and Data System (PI-RADS) is a widely-adopted framework for assessing prostate cancer risk using multiparametric MRI. However, as advancements in imaging and data analytics emerge, PI-RADS faces pressure to integrate novel quantitative techniques, enhanced imaging protocols, and artificial intelligence (AI) solutions to improve diagnostic accuracy. This review examines the recent innovations in advanced imaging, clinical, and AI methods that can provide more informative MRI scans and discuss their potential incorporation into PI-RADS. Techniques like multi-shot echo-planar imaging and reduced field-of-view DWI show promise in improving scan quality, but may present challenges with respect to technical complexity, cost, and standardization. Others, like restriction spectrum imaging and luminal water imaging, offer new possibilities for lesion characterization, yet remain difficult to implement consistently across clinical settings. In addition, integrating clinical parameters and AI-driven tools within PI-RADS could enhance risk stratification, but may introduce greater complexity, potentially impacting ease-of-use. We discuss the implications of these advancements for PI-RADS, balancing the potential diagnostic benefits with the challenges of maintaining accessibility and reproducibility in clinical practice. This review provides a comprehensive overview of how emerging MRI techniques and AI may redefine prostate cancer imaging standards. Evidence Level: 5. Technical Efficacy: Stage 5.</p>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Magnetic Resonance Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jmri.29754","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

The Prostate Imaging-Reporting and Data System (PI-RADS) is a widely-adopted framework for assessing prostate cancer risk using multiparametric MRI. However, as advancements in imaging and data analytics emerge, PI-RADS faces pressure to integrate novel quantitative techniques, enhanced imaging protocols, and artificial intelligence (AI) solutions to improve diagnostic accuracy. This review examines the recent innovations in advanced imaging, clinical, and AI methods that can provide more informative MRI scans and discuss their potential incorporation into PI-RADS. Techniques like multi-shot echo-planar imaging and reduced field-of-view DWI show promise in improving scan quality, but may present challenges with respect to technical complexity, cost, and standardization. Others, like restriction spectrum imaging and luminal water imaging, offer new possibilities for lesion characterization, yet remain difficult to implement consistently across clinical settings. In addition, integrating clinical parameters and AI-driven tools within PI-RADS could enhance risk stratification, but may introduce greater complexity, potentially impacting ease-of-use. We discuss the implications of these advancements for PI-RADS, balancing the potential diagnostic benefits with the challenges of maintaining accessibility and reproducibility in clinical practice. This review provides a comprehensive overview of how emerging MRI techniques and AI may redefine prostate cancer imaging standards. Evidence Level: 5. Technical Efficacy: Stage 5.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.70
自引率
6.80%
发文量
494
审稿时长
2 months
期刊介绍: The Journal of Magnetic Resonance Imaging (JMRI) is an international journal devoted to the timely publication of basic and clinical research, educational and review articles, and other information related to the diagnostic applications of magnetic resonance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信